Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [21] Kinetically selective and potent inhibitors of HDAC8
    Schweipert, Markus
    Jaensch, Niklas
    Sugiarto, Wisely Oki
    Meyer-Almes, Franz-Josef
    BIOLOGICAL CHEMISTRY, 2019, 400 (06) : 733 - 743
  • [22] Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors
    Banerjee, Suvankar
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (18) : 5513 - 5525
  • [23] Homology Modeling and Molecular Docking Studies on the Selectivity of HDAC1/HDAC8
    Zhang Yuan
    Chen Ya-Dong
    You Qi-Dong
    Zou Li-Yun
    Yang Yan
    ACTA PHYSICO-CHIMICA SINICA, 2010, 26 (06) : 1676 - 1686
  • [24] The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity
    Negmeldin, Ahmed T.
    Pflum, Mary Kay H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3254 - 3258
  • [25] Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
    Sarkar, Rajat
    Banerjee, Suvankar
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 192
  • [26] Azetidinones as Zinc-Binding Groups to Design Selective HDAC8 Inhibitors
    Galletti, Paola
    Quintavalla, Arianna
    Ventrici, Caterina
    Giannini, Giuseppe
    Cabri, Walter
    Penco, Sergio
    Gallo, Grazia
    Vincenti, Silvia
    Giacomini, Daria
    CHEMMEDCHEM, 2009, 4 (12) : 1991 - 2001
  • [27] Novel HDAC8 inhibitors: A multi-computational approach
    Manal, M.
    Manish, K.
    Sanal, D.
    Selvaraj, A.
    Devadasan, V.
    Chandrasekar, M. J. N.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (09) : 707 - 733
  • [28] Discovery of histone deacetylase 8 selective inhibitors
    Tang, Weiping
    Luo, Tuoping
    Greenberg, Edward F.
    Bradner, James E.
    Schreiber, Stuart L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2601 - 2605
  • [29] Development of a Potent and Selective HDAC8 Inhibitor
    Ingham, Oscar J.
    Paranal, Ronald M.
    Smith, William B.
    Escobar, Randolph A.
    Yueh, Han
    Snyder, Tracy
    Porco, John A., Jr.
    Bradner, James E.
    Beeler, Aaron B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 929 - 932
  • [30] Pathological Role of HDAC8: Cancer and Beyond
    Kim, Ji Yoon
    Cho, Hayoung
    Yoo, Jung
    Kim, Go Woon
    Jeon, Yu Hyun
    Lee, Sang Wu
    Kwon, So Hee
    CELLS, 2022, 11 (19)